Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-masked trial to examine the response to trabeculectomy
surgery. In this study, patients will be randomized to receive MMC via subconjunctival
injection or topical sponge application.
Phase:
N/A
Details
Lead Sponsor:
Francis I. Proctor Foundation University of California, San Francisco